| Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report. | |
| | |
MedLine Citation:
|
PMID: 16755453 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Giant cell myocarditis (GCM) is a rare and frequently fatal disorder. Patients suffer of ventricular arrhythmias or congestive heart failure. Here we describe a patient with cardiogenic shock and histological verified GCM. The patient was saved by implantation of extracorporeal membrane oxygeneation (ECMO) device and concomitant application of Rabbit antithymocyte globuline (rATG, Thymoglobulin, Sangstat), cyclosporine, and steroids in the acute event. 12 months after the crisis the patient evidences NYHA class I heart function and only a moderate impairment of heart function (EF 55%). The novel utilisation of ECMO in GCM related cardiogenic shock and application of rATG have prooven life-saving in this patient. Studies utilizing rATG in the treatment of GCM are warrented. |
| | |
Authors:
|
H J Ankersmit; R Ullrich; B Moser; K Hoetzenecker; S Hacker; P German; C Krenn; R Horvat; M Grimm; E Wolner; A Zuckermann |
Related Documents
:
|
17640543 - Pathophysiology of cardiogenic shock complicating acute myocardial infarction. 19091283 - A single implantable cardioverter-defibrillator shock unmasking an electrical storm of ... 8262083 - Graduated compression stockings in the prevention of deep vein thrombosis in patients w... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Thoracic and cardiovascular surgeon Volume: 54 ISSN: 0171-6425 ISO Abbreviation: Thorac Cardiovasc Surg Publication Date: 2006 Jun |
Date Detail:
|
Created Date: 2006-06-06 Completed Date: 2006-11-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7903387 Medline TA: Thorac Cardiovasc Surg Country: Germany |
Other Details:
|
Languages: eng Pagination: 278-80 Citation Subset: IM |
Affiliation:
|
Department of Cardiothoracic Surgery, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria. hjankersmit@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antilymphocyte Serum
/
therapeutic use* Extracorporeal Membrane Oxygenation* Giant Cells / pathology* Humans Immunologic Factors / therapeutic use* Male Middle Aged Myocarditis / drug therapy, pathology, therapy* Shock, Cardiogenic / drug therapy, pathology, therapy* T-Lymphocytes / immunology Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antilymphocyte Serum; 0/Immunologic Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surgical repair of the aortic coarctation combined with complete replacement of the ascending aorta ...
Next Document: Endobronchial lipoma in a patient with Churg-Strauss syndrome.